GALLAHUE KIERAN has filed 12 insider transactions across 2 companies since May 2023.
Most recent transaction: a grant/award of 10450 shares of Envista Holdings Corp ($NVST) on June 10, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 10, 2025 | Envista Holdings Corp | $NVST | GALLAHUE KIERAN | Director | A | Common Stock | 10450 | $0.00 | 44,680.0000 | 172,200,000 | 30.53% | 0.01% |
| May 9, 2025 | Edwards Lifesciences Corp | $EW | GALLAHUE KIERAN | Director | A | Common Stock | 3528 | $0.00 | 78,502.0000 | 655,900,000 | 4.71% | 0.00% |
| May 9, 2025 | Edwards Lifesciences Corp | $EW | GALLAHUE KIERAN | Director | A | Common Stock | 1154 | $0.00 | 79,656.0000 | 655,900,000 | 1.47% | 0.00% |
| May 21, 2024 | Envista Holdings Corp | $NVST | GALLAHUE KIERAN | Director | A | Common Stock | 10085 | $0.00 | 34,230.0000 | 166,900,000 | 41.77% | 0.01% |
| May 8, 2024 | Edwards Lifesciences Corp | $EW | GALLAHUE KIERAN | Director | A | Common Stock | 999 | $0.00 | 74,974.0000 | 651,800,000 | 1.35% | 0.00% |
| May 8, 2024 | Edwards Lifesciences Corp | $EW | GALLAHUE KIERAN | Director | A | Common Stock | 3055 | $0.00 | 73,975.0000 | 651,800,000 | 4.31% | 0.00% |
| Feb. 23, 2024 | Edwards Lifesciences Corp | $EW | GALLAHUE KIERAN | Director | G | Common Stock | 7056 | $0.00 | 73,978.0000 | 650,500,000 | 10.54% | 0.00% |
| Feb. 23, 2024 | Edwards Lifesciences Corp | $EW | GALLAHUE KIERAN | Director | M | Common Stock | 7056 | $36.86 | 77,976.0000 | 650,500,000 | 9.95% | 0.00% |
| Feb. 23, 2024 | Edwards Lifesciences Corp | $EW | GALLAHUE KIERAN | Director | G | Common Stock | 7056 | $0.00 | 70,920.0000 | 650,500,000 | 9.05% | 0.00% |
| Feb. 23, 2024 | Edwards Lifesciences Corp | $EW | GALLAHUE KIERAN | Director | S | Common Stock | 3058 | $87.61 | 70,920.0000 | 650,500,000 | 4.13% | 0.00% |
| Feb. 23, 2024 | Edwards Lifesciences Corp | $EW | GALLAHUE KIERAN | Director | M | Director Stock Option (Right to Acquire) | 7056 | $0.00 | 0.0000 | 650,500,000 | 100.00% | 0.00% |
| May 23, 2023 | Envista Holdings Corp | $NVST | GALLAHUE KIERAN | Director | A | Common Stock | 5425 | $0.00 | 24,145.0000 | 177,600,000 | 28.98% | 0.00% |